Helen Rizos

Professor

  • 3084 Citations
  • 34 h-Index
1989 …2022
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
Melanoma Medicine & Life Sciences
Tumor Suppressor Protein p14ARF Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Tumors Chemical Compounds
Mutation Medicine & Life Sciences
Melanocytes Medicine & Life Sciences
Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2022

Centre of Research Excellence in Melanoma: Person, tumour and system-focussed knowledge to drive better outcomes in melanoma

Braithwaite, J., Mann, G. J., Cust, A. E., Scolyer, R. A., Kelly, J., Morton, R. L., Spillane, A. J., Saw, R., Henderson, M., Yang, J. Y. H., Hong, A., Tran, A., Gyorki, D., Milne, D., Long, G. V., Rizos, H., Kasparian, N., Fernández-Peñas, P. & Guitera, P.

1/01/1831/12/22

Project: Other

Research Output 1989 2019

Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1 based immunotherapy

Lim, S. Y., Lee, J. H., Nur Gide, T., Menzies, A. M., Guminski, A., Carlino, M. S., Breen, E., Yang, J. Y. H., Ghazanfar, S., Kefford, R. F., Scolyer, R. A., Long, G. V. & Rizos, H., Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1557-1563 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Immunotherapy
Melanoma
Cytokines
Confidence Intervals
Therapeutics

Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In : Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Immunotherapy
Melanoma
MAP Kinase Signaling System
Atlases
Dual Specificity Phosphatase 6

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

Lee, H., Quek, C., Silva, I., Tasker, A., Batten, M., Rizos, H., Lim, S. Y., Nur Gide, T., Shang, P., Attrill, G. H., Madore, J., Edwards, J., Carlino, M. S., Guminski, A., Saw, R. P. M., Thompson, J. F., Ferguson, P. M., Palendira, U., Menzies, A. M., Long, G. V. & 2 othersScolyer, R. A. & Wilmott, J. S., Feb 2019, In : OncoImmunology. 8, 2, p. 1-10 10 p., e1537581.

Research output: Contribution to journalArticleResearchpeer-review

Natural Killer Cells
Melanoma
Major Histocompatibility Complex
Therapeutics
Neoplasms

Monitoring melanoma using circulating free DNA

Diefenbach, R. J., Lee, J. H. & Rizos, H., 13 Feb 2019, In : American Journal of Clinical Dermatology. 20, 1, p. 1-12 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Melanoma
Nucleic Acids
DNA
Polymerase Chain Reaction
Mutation

Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti–programmed cell death 1 antibodies

Lee, J. H., Long, G. V., Menzies, A. M., Lo, S., Guminski, A., Whitbourne, K., Peranec, M., Scolyer, R., Kefford, R. F., Rizos, H. & Carlino, M. S., 1 May 2018, In : JAMA Oncology. 4, 5, p. 717-721 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Melanoma
Cell Death
Antibodies
DNA
Neoplasms

Prizes